For this reason, clinicians make use of additional tools such as infection prediction scores, i.e., combinations of clinical evaluations and readily available laboratory screening tests such as complete blood counts and C-reactive protein (CRP) tests, to guide decisions regarding empiric antimicrobial treatment initiation in neonates suspected to have HAI (13–15). The gene discussed is CRP; the disease is nosocomial infection.